Patents by Inventor David Gertz

David Gertz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8961502
    Abstract: The invention provides a device and method for illuminating a body surface. A light source is optically coupled to the proximal end of a light guide and a light scatterer is optically coupled to the distal end of the light guide. The device includes a deployment mechanism that is configured to bring the light scatterer from a small caliber configuration in which the light scatterer is delivered to the body surface to a large caliber configuration in which the light scatterer irradiates the body surface. The invention may be used, for example, irradiate the periadventitial surface of an aneurysmal blood vessel.
    Type: Grant
    Filed: April 10, 2007
    Date of Patent: February 24, 2015
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd.
    Inventors: David Gertz, Lilach Gavish, Petachia Reissman
  • Publication number: 20120095532
    Abstract: The present invention provides an apparatus and method for the internal treatment of body cavities and damaged internal vessels using irradiation. A device and method according to the invention may be used to irradiate an internal tissue surface, for example, for the treatment of an aneurysm, tissue welding, or the removal of a stenosis in a blood vessel. In one embodiment, the invention provides a device for illuminating a body surface including a shaft having a light guide, a control unit, and a light scatterer. The control unit includes a light source optically coupled to the light guide; and the light scatterer is optically coupled to the light guide. The light scatterer includes a first, rear surface and a second, forward illuminating surface, and the light scatterer has a first undeployed, collapsed configuration and a second deployed configuration in which the illuminating surface has a larger caliber than in the first undeployed, collapsed configuration.
    Type: Application
    Filed: November 3, 2009
    Publication date: April 19, 2012
    Inventors: David Gertz, Lilach Gavish
  • Publication number: 20090287194
    Abstract: The invention provides a device and method for illuminating a body surface. A light source is optically coupled to the proximal end of a light guide and a light scatterer is optically coupled to the distal end of the light guide. The device includes a deployment mechanism that is configured to bring the light scatterer from a small caliber configuration in which the light scatterer is delivered to the body surface to a large caliber configuration in which the light scatterer irradiates the body surface. The invention may be used, for example, irradiate the periadventitial surface of an aneurysmal blood vessel.
    Type: Application
    Filed: April 10, 2007
    Publication date: November 19, 2009
    Applicant: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM
    Inventors: David Gertz, Lilach Gavish, Petachia Reissman
  • Patent number: 6358954
    Abstract: An isometric enriched tyrphostin of a general formula: wherein, for Compound I, the tyrphostin is enriched either for R6 at position 6 or for R6 at position 7, or, for Compound II, the tyrphostin is enriched either for R6 at position 6 or for R6 at position 8. Further disclosed are pharmaceutical compositons containing the isometric enriched tyrphostin and methods of using same to treat cell proliferative diseases.
    Type: Grant
    Filed: November 9, 1999
    Date of Patent: March 19, 2002
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Alexander Levitzki, Aviv Gazit, Shmuel Banai, S. David Gertz, Gershon Golomb, Frank D. Boehmer, Johannes Waltenberger
  • Patent number: 5932580
    Abstract: PDGF receptor kinase inhibitory compounds of the quinoxaline family, methods for their synthesis and containment is slow release pharmaceutical preparations, and their use for treatment of proliferative malignant and non-malignant diseases or disorders by local or systemic application. A compound according to the invention includes a tyrphostin of the general formula: ##STR1## wherein R1 and R2 are each independently selected from the group consisting of alkyl, alkoxy, halogen, nitro and amine and Ar is selected from the group consisting of phenyl, ferrocene, thiophene, furane, pyrrole, indole, thiazole, imidazole and pyridine.
    Type: Grant
    Filed: December 1, 1997
    Date of Patent: August 3, 1999
    Assignee: Yissum Research and Development Company of the Hebrew University of Jerusalem
    Inventors: Alexander Levitzki, Aviv Gazit, Shmuel Banai, S. David Gertz, Gershon Golomb